AI-Driven Oncology Diagnostics Account Executive

Scorpion Therapeutics; Town of Florida (NY); On-site; USD 100,000 - 160,000; Full time

Job summary

Scorpion Therapeutics is seeking an Account Executive for MI Clarity to drive awareness, adoption, and utilization of an AI-powered prognostic assay in HR+/HER2-, node-negative early-stage breast cancer. You will educate providers, present clinical data, and integrate this assay into breast cancer workflows.

Responsibilities include developing territory plans, building relationships with clinicians, and collaborating with Medical Affairs, Marketing, and Operations to accelerate adoption and

Qualifications

• Bachelor’s degree in life sciences or healthcare preferred.
• 3+ years sales experience in oncology/diagnostics.
• Strong knowledge of breast cancer pathways and clinical data.
• Proven ability to build provider relationships and present data.

Responsibilities

• Educate providers on MI Clarity clinical utility and prognostic value.
• Present clinical data and differentiation vs traditional assays.
• Lead consultative discussions on risk stratification and treatment planning.
• Position MI Clarity as clinical decision-support; address workflow and turnaround time.
• Develop territory/account plans to drive adoption and utilization.
• Build relationships with oncologists, surgeons, pathologists, APPs, and health-system decision-makers.
• Identify key opinion leaders to support adoption.
• Support testing workflow implementation and operational integration.
• Analyze account data; monitor trends; target engagement opportunities.
• Maintain accurate CRM documentation and forecasting.
• Collaborate cross-functionally with Medical Affairs, Marketing, Operations, and Customer Support.

Skills

Oncology sales

Clinical data

Relationship building

Presentation skills

Education

Bachelor’s degree

Job description

Scorpion Therapeutics is seeking an Account Executive for MI Clarity to drive awareness, adoption, and utilization of an AI-powered prognostic assay in HR+/HER2-, node-negative early-stage breast cancer. You will educate providers, present clinical data, and integrate this assay into breast cancer workflows.

Responsibilities include developing territory plans, building relationships with clinicians, and collaborating with Medical Affairs, Marketing, and Operations to accelerate adoption and